Arthur J. Higgins
2019 - DepoMed
In 2019, Arthur J. Higgins earned a total compensation of $4.9M as President and Chief Executive Officer at DepoMed, a 2% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $793,040 |
|---|---|
| Salary | $800,000 |
| Stock Awards | $3,267,209 |
| Other | $9,120 |
| Total | $4,869,369 |
Higgins received $3.3M in stock awards, accounting for 67% of the total pay in 2019.
Higgins also received $793K in non-equity incentive plan, $800K in salary and $9.1K in other compensation.
Rankings
In 2019, Arthur J. Higgins' compensation ranked 2,294th out of 13,971 executives tracked by ExecPay. In other words, Higgins earned more than 83.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,294 out of 13,971 | 84th |
Division Manufacturing | 829 out of 5,701 | 86th |
Major group Chemicals And Allied Products | 265 out of 2,200 | 88th |
Industry group Drugs | 213 out of 1,886 | 89th |
Industry Pharmaceutical Preparations | 155 out of 1,398 | 89th |
Source: SEC filing on April 20, 2020.
Higgins' colleagues
We found two more compensation records of executives who worked with Arthur J. Higgins at DepoMed in 2019.
News
Assertio Holdings CEO Arthur Higgins' 2020 pay falls 48% to $2.5M
April 12, 2021
Egalet CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
April 20, 2020
DepoMed CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
April 20, 2020
Egalet CEO Arthur Higgins' 2018 pay stays at $4.8M
November 6, 2019
DepoMed CEO Arthur Higgins' 2018 pay stays at $4.8M
April 8, 2019